出错啦！
您访问的页面不存在！
微博
最新新闻稿
- 2026-09-30 15:29
SES and Sky Sign Multi-Year Satellite Capacity Agreement - 2026-09-30 15:26
EADV 2026: Galderma’s New Data Show Sustained Improvements with Nemluvio® (nemolizumab) for up to Three Years in Patients With Moderate-to-severe Atopic Dermatitis - 2026-09-30 15:23
Zasocitinib Delivered Superior Efficacy Versus Deucravacitinib in New Phase 3 Head-to-Head Results, Reinforcing Potential to Deliver Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill - 2026-09-30 15:21
Ant International’s Antom Supports Google Gemini in Expanding Access to AI Service in Asia - 2026-09-30 15:18
SES Successfully Prices €500 million Eurobond
